Robotic surgery conducted on breast-cancer patient; Delhi hospital says '1st in north India'
oncological surgery
at a Delhi hospital that has claimed it to be a first in north India. The woman had a history of recurrent breast cancer and
BRCA gene mutation
.
#Operation Sindoor
India-Pakistan Clash Live Updates| Pak moving troops to border areas? All that's happening
Why India chose to abstain instead of 'No Vote' against IMF billion-dollar funding to Pakistan
How Pak's jihadi general Munir became trapped in his own vice
She had undergone multiple cancer treatments and surgeries since 2017 and was admitted to the Indraprastha Apollo Hospital for a
bilateral breast surgery
due to her being on high risk of future breast cancer, involving a combination of conventional and robotic-assisted techniques.
The surgery was carried out by a team of specialists, including Dr Ramesh Sarin, Senior Consultant-Surgical Oncology, Dr Arun Prasad, Senior Consultant-Gastrointestinal, Bariatric and Robotic Surgery, Dr Parag Sharma, Dr Jayanti Tumsi and Dr Sandip Bipte, the hospital said in a statement.
The patient was diagnosed with triple-negative breast cancer in 2017.
Over the years, she underwent chemotherapy, multiple lumpectomies, radiotherapy and a salpingo-oophorectomy.
Live Events
Her BRCA-positive status further elevated the risk of recurrence, necessitating the preventive and reconstructive bilateral breast surgery, the statement said.
After thorough evaluation and counselling, the surgical team devised a comprehensive plan that incorporated robotic technology on one side and advanced reconstructive techniques on the other, it said.
The team utilised the
da Vinci Robotic Surgical System
to perform a nipple-sparing mastectomy on the right breast, while the left breast, which was previously treated twice with lumpectomies and radiation, underwent conventional mastectomy and reconstruction, using a musculo-cutaneous flap and implant.
The robotic approach enabled enhanced precision and control, minimising surgical trauma and preserving the surrounding tissues. The patient tolerated the procedure well, made a swift recovery and was discharged in a stable condition, the statement said.
"This procedure represents the future of breast-cancer surgery, especially with healthy breast needs to be removed to protect for future cancer development. The case selectiveness for such surgeries must be stringent," Dr Sarin said.
She also spoke about how robotic-assisted techniques enable highly-precise excision of cancerous tissues while preserving the surrounding healthy tissues.
Commenting on the success of the procedure, Dr Prasad emphasised that the introduction of robotic breast surgery in north India marks a transformative step forward in the field of surgical oncology.
"Robotic-assisted procedures offer unmatched precision, particularly in complex cancer cases, where every millimetre matters. Such technology not only enhances surgical accuracy but also helps preserve vital structures, reduce operative trauma and deliver superior cosmetic and functional outcomes. This innovation is more than just a technological upgrade, it is a paradigm shift in how we approach cancer surgery, combining clinical excellence with compassionate, patient-centred care," he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
5 hours ago
- Hindustan Times
Gujarat HC orders CRPF to promote HIV-positive officer in ministerial posts
The Gujarat high court has ordered the Central Reserve Police Force (CRPF) to promote a woman officer to the Inspector rank, ruling that the force could not stop her promotion to the ministerial post merely on the ground that she was HIV-positive. The Gujarat high court ordered CRPF to promote her as Inspector (Ministerial) with effect from the date her juniors were promoted, and consider her for promotion to the post of Assistant Commandant (Ministerial) The high court ordered CRPF to promote her as Inspector (Ministerial) with effect from the date her juniors were promoted, and consider her for promotion to the post of Assistant Commandant (Ministerial) by placing her in the gradation list along with her juniors. A special departmental promotion committee should be conducted to consider the petitioner's candidature. 'Upon consideration, if the petitioner is found fit on all other aspects, she shall be given promotion to the post of Assistant Commandant (Ministerial) from the date the junior(s) to her have been promoted against the vacancies of the year 2024-25,' a bench of chief justice Sunita Agarwal and justice Pranav Trivedi said in its verdict on Monday. The detailed judgment was uploaded to the high court's website on Tuesday. The court ruled that the entire exercise should be completed within two months. The petitioner, a CRPF officer who was diagnosed HIV-positive in 2013, was denied promotion on multiple occasions despite being medically classified as Shape-I — the highest fitness level — between 2017 and 2022. In 2024, she was temporarily placed in Shape-II for 12 weeks, despite a CD4 count of 562. On that basis, her name was excluded from the list of officers considered for promotion to the post of Assistant Commandant (Ministerial). 'Applying the medical category Shape I as an essential (pre-requisite) condition for promotion of the force personnel in all groups/ranks/cadres in the CPMF and, thus, denying promotion to HIV/AIDS +ve persons who are 'protected persons' within the HIV/AIDS (Prevention & Control) Act' 2017 resulted in arbitrary exercise of powers at the ends of the respondents,' the court said. The CRPF had tried to argue that medical classification in Shape-I was a mandatory requirement for promotion and cited Standing Orders and Recruitment Rules. It also sought to reason that promotion could not be claimed as a matter of right and that the petitioner's exclusion was based on applicable policy and medical reports. It also claimed that while she had been temporarily upgraded to Shape-I in the past, she did not appear for timely review medical examinations as required, including in 2024, which affected her eligibility. The officer, on the other hand, said that she had been consistently declared fit for service, with CD4 counts well above the clinical minimum of 200 cells/microlitre, and that she had been arbitrarily downgraded in the medical system without consistency. She said she was denied promotion despite meeting the eligibility and superior Annual Performance Appraisal Reports. She also argued that applying the same physical medical standards to ministerial staff — who do not serve in combat or field duties — was irrational and discriminatory. The bench agreed with the petitioner's arguments. The court ruled that the current rules and standing orders placed an unlawful restriction on DPCs by denying them discretion to assess overall fitness. It stated: 'It seems that HIV/AIDS +ve persons are being treated in the force as the persons suffering from illness of permanent nature and, as such, they are either being declared unfit by DPC even though they are otherwise fit for promotion or not even included in the list placed before the DPC for consideration for promotion on the ground that they do not fall in Shape-I category. This is what has exactly happened with the petitioner herein,' the court observed.
India Today
6 hours ago
- India Today
Bananas, potatoes, and a heart attack? What doctors want you to know
When the discussion is around heart health in India, we mostly think of cholesterol, blood pressure, or sometimes even clogged arteries. However, there's a quieter danger that is lurking in plain sight: high potassium, or is becoming one of the biggest concerns for cardiac specialists worldwide. Some even warn that hyperkalemia could soon be a leading cause of cardiac issues in young, seemingly healthy is, of course, essential for your heart's electrical rhythm, but if levels rise even slightly above normal, your heartbeat can go dangerously off track. 'It's often called the body's electrician because without adequate potassium, the electrical signals in the body can suffer a glitch. This in turn may compel the heart to lose its sync,' explains Dr. Anjali Mehta, a Mumbai-based cardiologist. Even a small imbalance, she notes, can lead to arrhythmias and, in severe cases, sudden cardiac arrest. Major contributors to this sudden spike in potassium can be blamed on our lifestyle and diet. It's not uncommon in Indian families that bananas and potatoes are termed to be healthy for their high potassium content and, for most people, they may be. But as Dr. Mehta points out, "For those who are diagnosed with severe kidney issues, diabetes, or high blood pressure, these everyday foods may quietly push the heart into danger.'IS IT COMMONLY KNOWN?Unfortunately, we don't have much India-specific data on hyperkalemia. Globally, it affects about 1–5% of the general population, and around 1–2% of hospitalised patients. In patients with chronic kidney disease or on medications like ACE inhibitors, the prevalence rate goes up significantly to 7–8% or sometimes even more.A Reddit post by students who study medicine in India recently talked about a 65yearold MI patient with potassium of 6.5, prompting immediate repeat testing and emergency post depicts how hyperkalemia is taken seriously in Indian clinical training even though formal studies are LEVELS: SAFE Vs LETHALHere's the usual scale:Potassium Level (mEq/L)Risk LevelSymptoms3.5–5.0NormalNothing5.1–6.0MildFatigue6.1–7.0ModeratePalpitations, weakness, ECG changes>7.0SevereHigh risk of cardiac arrest'In one ICU case, we saw an asymptomatic patient with K of 5.1 mEq/L—absolutely fine. No ECG until >5.5 mEq/L. The patient suffered a heart attack in the next half hour," says Dr Nimit Jain, a retired cardiac surgeon from AIIMS in New problem, Dr Jain explains, is that the symptoms often go unnoticed, but that doesn't mean they are not harmful."The symptoms of high potassium are usually very subtle. It includes weakness, numbness or tingling in limbs, nausea followed by unexplained palpitations, and shortness of breath. These often get chalked up to stress or dehydration. In a busy Indian clinic, people seldom connect these mild feelings to a life-threatening electrolyte imbalance and that's the start of the problem," he REALITY CHECKadvertisementIndia has one of the world's highest rates of diabetic kidney disease and such patients are at maximum risk of elevated potassium levels, which can lead to serious cardiac kidneys struggle to flush excess potassium, increasing risk fast. Some patients who have been advised to take ACE inhibitors, or ARBs, and other diuretics for managing their blood pressure should also be mindful of potassium levels in their body. These medicines are known to increase potassium, even in people with moderate kidney diet, which consists of bananas, leafy greens, tomatoes, and potatoes, can become risky if your kidneys or medications raise your potassium a simple process to follow. If you are taking over-the-counter potassium supplements or salt substitutes which contain potassium chloride, inform your doctor about it. Also mention vague symptoms, even if they are mild, to your doctor. If your level is >6.0 mEq/L, or ECG shows peaked Twaves, immediate treatment is essential," warns Dr it treatable? Yes, says Dr Mihir Desai, a cardiologist from Hyderabad. "Treatment for potassium depends on its severity. For patients with mild levels (5.1–6.0), we advise them to just adjust their diet and repeat tests. Those who have moderate to severe levels (6.5) require IV calcium gluconate to stabilise the heart immediately."advertisementApart from the calcium intravenously, patients with high levels of potassium are also advised to take Insulin + glucose salbutamol nebuliser to shift potassium into the cells. Sometimes, potassium-binding drugs or a kidney dialysis is also India, where diabetes and kidney disease are common, high potassium is a real but underappreciated threat. The problem is that it doesn't yell, it only whispers. Are we listening?- Ends
Economic Times
13 hours ago
- Economic Times
Promising HIV cure could be achieved through children: Decade long tests reveal
Cure for HIV emerges in children with early antiretroviral treatment New evidence from global HIV research suggests that the first widespread cure for HIV may be possible in children who receive antiretroviral therapy (ART) early in life. Pediatrician and immunologist Philip Goulder from the University of Oxford, working with researchers in South Africa, found that a small subset of HIV-infected infants treated soon after birth can suppress the virus to undetectable levels and maintain remission without ongoing medication for extended periods. After tracking several hundred children infected through mother-to-child transmission, Goulder's team was astonished to find five children who had stopped ART yet showed no viral rebound even after months off medicine, defying the typical two to three weeks it takes for HIV to return when treatment is interrupted. One child maintained remission for an unprecedented 17 months. These children's immune systems appear uniquely capable of controlling HIV independently, a phenomenon not seen in adults despite decades of research. According to Alfredo Tagarro, a pediatrician at the Infanta Sofia University Hospital in Madrid, children living with HIV have often been overlooked in the effort to develop treatments that can achieve permanent remission. Since 2007, about 10 adults are believed to have been cured of HIV through stem cell transplants intended to treat life-threatening blood cancers. While these procedures successfully eradicated the virus, their complexity and significant risks—including several patient deaths—make them an impractical approach for targeting HIV specifically. At the 2025 International AIDS Society conference in Kigali, additional data showed approximately 5% of HIV-positive children initiating ART within six months of birth could reduce the viral reservoir—genetic material of the virus hidden in cells—to negligible levels. Pediatric experts attribute children's more dynamic immune systems and fewer health complications as factors that may enable this early cure. Mark Cotton of the University of Stellenbosch emphasized children's suitability for curative therapies compared to adults with comorbidities. Building on these insights, Goulder has launched a new study involving 19 South African children who have suppressed HIV reservoirs under ART. He plans to carefully discontinue treatment and monitor how many keep the virus suppressed long-term. Early results show six children maintaining remission for more than 18 months without drugs. Boys may have an immunological advantage in controlling HIV due to innate immune system experimental treatments are also being explored in children, including gene therapy designed to make muscle cells continuously produce broadly neutralizing antibodies (bNAbs). This one-time therapy could protect infants in high-prevalence regions by preventing HIV transmission from birth or breastfeeding. Research in newborn monkeys highlights a critical early window post-birth when gene therapy is most effective, potentially revolutionizing pediatric HIV care in resource-limited recent funding setbacks, researchers remain optimistic. Combining ART with bNAbs, vaccines, and gene therapies may jointly corner and eliminate the virus, similar to successful pediatric leukemia treatments. While children represent a minority of global HIV cases, a cure in this group could provide the blueprint for universal HIV eradication global impact could be profound: about 1.7 million children worldwide live with HIV, many in low-income countries where lifelong ART adherence is challenging. An effective cure would drastically reduce the health and social burdens of pediatric HIV and pave the way for transforming HIV from a chronic condition into a curable breakthrough marks a historic turning point in the decades-long fight against HIV, with children potentially leading the route to a cure and offering hope for millions affected worldwide.
